9 Results for "

PDE3/4

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "PDE3/4" in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-B0140
CAS No.: 317-34-0
Aminophylline is a competitive phosphodiesterase 3/4 (PDE3/4) inhibitor. Aminophylline also acts as an adenosine receptor antagonist. Aminophylline elevates intracellular cAMP levels via competitive inhibition of PDE3 and PDE4, antagonizes adenosine A1 receptor (ADORA1), regulates intracellular calcium signaling and synaptic vesicle cycling, upregulates the PPAR signaling pathway, and downregulates glutamatergic synaptic pathways simultaneously. Aminophylline can be used in research related to major depressive disorder, epilepsy, asthma, and chronic obstructive pulmonary disease (COPD) [3] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15485
CAS No.: 101975-10-4
Purity:  98.59%
Zardaverine is an orally active and selective PDE3/4 inhibitor (IC50)=0.58 uM/0.17 uM) with potent bronchodilator activity. Zardaverine also selectively inhibits the proliferation of HCC cells and induces apoptosis and cycle arrest (G0/G1 phase). Zardaverine has good antitumor potential and is effective in both bronchial relaxation and reduction of inflammation in asthma [3].
loading...
    loading...
Cat. No.: HY-174383
CAS No.: 2857007-03-3
Research Areas:  

Inflammation/Immunology

PDE3/4-IN-2 is a dual PDE3A and PDE4B1 inhibitor, with an IC50 of 0.13 nM against PDE3A and 50 nM against PDE4B1. PDE3/4-IN-2 exhibits higher systemic exposure and longer retention time in lung tissues in ICR mice. PDE3/4-IN-2 can be used in research on respiratory diseases such as asthma and chronic obstructive pulmonary disease, as well as autoimmune inflammation-related studies .
loading...
    loading...
Cat. No.: HY-176524S
CAS No.: 2939748-69-1
PDE3/4-IN-3 (Compound 7) is an orally active dual PDE3/4 inhibitor with IC50 s of 0.17 and ≤50 nM for PDE3A and PDE4B2, respectively. PDE3/4-IN-3 significantly inhibits methacholine-induced bronchoconstriction in guinea pigs. PDE3/4-IN-3 can be used for chronic obstructive pulmonary disease (COPD) and asthma research .
loading...
    loading...
Cat. No.: HY-181088
CAS No.: 3088024-27-2
PDE3/4-IN-4 is an orally active PDE3A and PDE4B inhibitor with IC50 values of 10 nM and 9.4 nM, respectively. PDE3/4-IN-4 shows selective activity relative to most other PDE family members. PDE3/4-IN-4 modulates the cAMP/PKA/CREB signaling pathway. PDE3/4-IN-4 inhibits pro-inflammatory factor IL-6. PDE3/4-IN-4 reduces expression of inflammatory markers in liver tissue. PDE3/4-IN-4 attenuates liver fibrosis. PDE3/4-IN-4 limits liver damage in cholestatic and sepsis-induced liver disease mice models. PDE3/4-IN-4 can be used for the research of liver injury, cholestatic liver diseases, sepsis-induced liver injury .
loading...
    loading...
Cat. No.: HY-125050
CAS No.: 909719-71-7
Research Areas:  

Inflammation/Immunology

KCA-1490 is a dual PDE3/4 inhibitor with IC50 values of 369 nM and 42 nM, respectively. KCA-1490 exhibits potent bronchodilatory and anti-inflammatory activity. KCA-1490 suppresses Histamine (HY-B1204)-induced bronchoconstriction in vivo, which is promising for research of asthma and chronic obstructive pulmonary disease (COPD) [3].
loading...
    loading...
Cat. No.: HY-W700639
CAS No.: 139308-65-9
Research Areas:  

Neurological Disease

Tolafentrine, a dual-selective phosphodiesterase 3/4 (PDE3/4) inhibitor, has been shown to have significant acute and chronic effects in a unilateral diacetamide-induced rat pulmonary hypertension model. Experiments show that long-term administration can significantly alleviate all unilateral bisacetamide-induced hemodynamic and gas exchange abnormalities, reduce right ventricular hypertrophy, and normalize pulmonary vascular remodeling changes .
loading...
    loading...
Cat. No.: HY-B0140R
CAS No.: 317-34-0
Aminophylline (Standard) is the analytical standard of Aminophylline (HY-B0140). This product is intended for research and analytical applications. Aminophylline is a competitive phosphodiesterase 3/4 (PDE3/4) inhibitor. Aminophylline also acts as an adenosine receptor antagonist. Aminophylline elevates intracellular cAMP levels via competitive inhibition of PDE3 and PDE4, antagonizes adenosine A1 receptor (ADORA1), regulates intracellular calcium signaling and synaptic vesicle cycling, upregulates the PPAR signaling pathway, and downregulates glutamatergic synaptic pathways simultaneously. Aminophylline can be used in research related to major depressive disorder, epilepsy, asthma, and chronic obstructive pulmonary disease (COPD) [3] .
loading...
    loading...
Cat. No.: HY-B0140A
CAS No.: 56440-60-9
Aminophylline Dihydrate is a competitive phosphodiesterase 3/4 (PDE3/4) inhibitor. Aminophylline Dihydrate also acts as an adenosine receptor (adenosine receptor) antagonist. Aminophylline Dihydrate elevates intracellular cAMP levels via competitive inhibition of PDE3 and PDE4, antagonizes the adenosine A1 receptor (ADORA1, regulates intracellular calcium signal transduction and synaptic vesicle recycling, upregulates the PPAR signaling pathway, and downregulates the glutamatergic synaptic pathway simultaneously. Aminophylline Dihydrate can be used in research related to major depressive disorder, epilepsy, asthma, and chronic obstructive pulmonary disease (COPD) [3] .
loading...
    loading...